Antimitochondrial antibody

Antimitochondrial antibodies (AMA) abubuwa ne (ƙwayoyin cuta) waɗanda ke haifar da mitochondria. Mitochondria wani muhimmin bangare ne na sel. Su ne tushen makamashi a cikin sel. Waɗannan suna taimaka wa ƙwayoyin aiki yadda ya kamata.

Wannan labarin yayi magana akan gwajin jini da aka yi amfani dashi don auna adadin AMA a cikin jini.

Ana bukatar samfurin jini. An fi ɗauke shi daga jijiya. Ana kiran hanyar da ake kira venipuncture.

Mai ba ka kiwon lafiya na iya gaya maka kada ka ci ko sha wani abu har zuwa awanni 6 kafin gwajin (mafi yawanci a cikin dare).

Lokacin da aka saka allurar don zana jini, wasu mutane suna jin matsakaicin ciwo. Wasu kuma ba sa jin wani abu kamar harbawa ko wani abu mai zafi. Bayan haka, ana iya samun wasu buguwa.

Kuna iya buƙatar wannan gwajin idan kuna da alamun cutar hanta. Wannan gwajin ana amfani dashi mafi yawa don gano asali cholangitis na farko, wanda ake kira da farko biliary cirrhosis (PBC).

Hakanan za'a iya amfani da gwajin don banbanta tsakanin cutar hanta da ke da alaƙa da cutar hanta saboda wasu dalilai kamar toshewarta, cututtukan hanta mai haɗari, ko kuma cutar maye.

A yadda aka saba, babu ƙwayoyin cuta.

Wannan gwajin yana da mahimmanci don bincikar PBC. Kusan duk mutanen da ke da yanayin za su gwada tabbatacce. Yana da wuya mutum ba tare da yanayin ya sami kyakkyawan sakamako ba. Koyaya, wasu mutane tare da tabbataccen gwaji don AMA kuma babu wata alamar cutar hanta na iya ci gaba zuwa PBC akan lokaci.

Ba da daɗewa ba, ana iya samun sakamako mara kyau wanda ya faru da wasu nau'o'in cututtukan hanta da wasu cututtukan autoimmune.

Haɗarin haɗari don zub da jini ba su da yawa amma zai iya haɗawa da:

• Zub da jini mai yawa
• Sumewa ko jin an sassauta kai
• Hematoma (jini yana taruwa a ƙarƙashin fata)
• Kamuwa (ƙananan haɗari kowane lokaci fata ta karye)

• Gwajin jini

Beuers U, Gershwin ME, Gish RG, et al. Canza nomenclature na PBC: Daga 'cirrhosis' zuwa 'cholangitis'. Clin Res Hepatol Gastroenterol. 2015; 39 (5): e57-e59. PMID: 26433440 www.ncbi.nlm.nih.gov/pubmed/26433440.

Chernecky CC, Berger BJ. A. A cikin: Chernecky CC, Berger BJ, eds. Gwajin Laboratory da hanyoyin bincike. Na 6 ed. St Louis, MO: Elsevier Saunders; 2013: 84-180.

Eaton JE, Lindor KD. Farkon biliary cirrhosis. A cikin: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger da cututtukan hanta da cutar Fordtran: Pathophysiology / Diagnosis / Management. 10 ed. Philadelphia, PA: Elsevier Saunders; 2016: babi na 91.

Kakar S. Primary biliary cholangitis. A cikin: Saxena R, ed. Hanyar Hanyar Hanyar Hanyar Hanyar Hanyar Hanya: Hanyar Bincike. 2nd ed. Philadelphia, PA: Elsevier; 2018: babi na 26.

Zhang J, Zhang W, Leung PS, et al. Ationaddamarwa na gudana na ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin cuta na ƙwayoyin cuta na farko. Hepatology. 2014; 60 (5): 1708-1716. PMID: 25043065 www.ncbi.nlm.nih.gov/pubmed/25043065.